Panacea Biotec has settled its lawsuit against Sanofi regarding a hexavalent vaccine, leading to the disposal of the suit by the Delhi High Court on September 13, 2024. Sanofi will not launch its vaccine in India and withdraw certain patent opposition claims, while Panacea Biotec will not pursue damages.